Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity

Biochem Biophys Res Commun. 2009 Aug 21;386(2):351-5. doi: 10.1016/j.bbrc.2009.06.040. Epub 2009 Jun 11.

Abstract

We previously described a putative role for inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme in de novo guanine nucleotide biosynthesis, in lipid accumulation. Here we present data which demonstrate that IMPDH activity is required for differentiation of preadipocytes into mature, lipid-laden adipocytes and maintenance of adipose tissue mass. In 3T3-L1 preadipocytes inhibition of IMPDH with mycophenolic acid (MPA) reduced intracellular GTP levels by 60% (p<0.05) and blocked adipogenesis (p<0.05). Co-treatment with guanosine, a substrate in the salvage pathway of nucleotide biosynthesis, restored GTP levels and adipogenesis demonstrating the specificity of these effects. Treatment of diet-induced obese mice with mycophenolate mofetil (MMF), the prodrug of MPA, for 28 days did not affect food intake or lean body mass but reduced body fat content (by 36%, p=0.002) and adipocyte size (p=0.03) and number. These data suggest that inhibition of IMPDH may represent a novel strategy to reduce adipose tissue mass.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipogenesis / drug effects*
  • Animals
  • Diet
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use*
  • Guanosine / pharmacology
  • IMP Dehydrogenase / antagonists & inhibitors*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / pharmacology
  • Mycophenolic Acid / therapeutic use
  • Obesity / drug therapy*
  • Obesity / enzymology
  • Weight Loss*

Substances

  • Enzyme Inhibitors
  • Guanosine
  • IMP Dehydrogenase
  • Mycophenolic Acid